Feed IPSEF
IP

Ipsen S.A. IPSEF · OTC

$113.13 +0.00% (+$0.00)

Summary

73 / 100 · Bulios Score

What speaks for it

  • It holds more cash than debt: 1.97B € against 961.8M €.
  • The share price is below the Bulios Fair Price.
  • Out of every 100 EUR of revenue, 12 EUR is left as net profit.
  • Analysts expect revenue to grow by 21% this fiscal year.

What to watch

  • Earnings per share fell by 12% a year over the last 3 years.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Current price $113.13
P/E today 18.7 15% higher
5-year average P/E 16.4
P/E today 18.7
Drug Manufacturers - Specialty & Generic industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 18.7 EUR for 1 EUR of yearly profit. Over the last five years it was 16.4 EUR on average.

Valuation in detail

Is it growing?

Slowly

Revenue (EUR)

Diluted EPS (EUR)

  • Analyst estimate

Revenue grew by 6.5% a year over 5 years. Over the last 3 years it grew by 5.2% a year. For the next fiscal year analysts expect revenue to grow by 21%. Earnings per share fell by 12% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 EUR of revenue goes

Net profit, industry median (Drug Manufacturers - Specialty & Generic) 10 EUR

Out of every 100 EUR of revenue, 12 EUR is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

It could repay all its debt from a single year of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

Small, safe
Yield
1.64%
Paid out of profit
31%
Raised in a row
1 year

You receive $1.86 per share a year. The company covers the payout with ease.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.